Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial

BACKGROUND: Palliative systemic treatment in elderly gynaecological cancer patients remains a major challenge. In recurrent ovarian cancer (ROC), treosulfan an active alkylating drug showed similar cytotoxicity whether as oral (p.o.) or intravenous (i.v.) application. The aim of this innovative tria...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gynecol Oncol Res Pract
Autors principals: Chekerov, Radoslav, Harter, Philipp, Fuxius, Stefan, Hanker, Lars Christian, Woelber, Linn, Müller, Lothar, Klare, Peter, Abenhardt, Wolfgang, Nedkova, Yoana, Yalcinkaya, Isil, Heinrich, Georg, Sommer, Harald, Mahner, Sven, Wimberger, Pauline, Koensgen-Mustea, Dominique, Richter, Rolf, Oskay-Oezcelik, Gülten, Sehouli, Jalid
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341434/
https://ncbi.nlm.nih.gov/pubmed/28286660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40661-017-0040-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars